Can tracking thousands of dementia cases reshape how we care for patients?
NCT ID NCT07721701
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study follows 5,000 people with mild cognitive impairment or mild-to-moderate dementia living at home in Bavaria, along with their family caregivers. Researchers collect detailed information on health, daily function, care needs, and quality of life over several years. The goal is to better understand how dementia progresses and how care can be improved, especially in rural areas.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could reveal patterns that improve dementia care and support services, especially in rural areas.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly test any therapy. The findings may take years to translate into practical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 5,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2020
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants are recruited and surveyed through institutions that are active in counseling, care, diagnosis, treatment, and care for people with dementia, including counseling facilities, care groups, and residential communities, as well as outpatient (memory clinics, outpatient care services, general practitioners and specialists), inpatient (acute care hospitals, district clinics, geriatric rehabilitation facilities) and semi-inpatient (geriatric day clinics, day care facilities) institutions
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * People with an MMSE score of 24-30 points and an additional MoCA score of 0-23 points * People with an MMSE score of 15-23 points * Living in a home environment * All types of MCI and dementia according to the ICD-10 classification (F06.7, F00-F03) * Main residence in Bavaria * All age groups Exclusion Criteria: * People with an MMST score of 24-30 points and an additional MoCA score of 24-30 points * People with an MMST score of 0-14 points * Permanent residence in a nursing home * Psychiatric diagnoses (among others depression, schizophrenia, addiction) * Deafness and/or blindness * Aphasia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
12 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Böhm-Peters - Praxis für Psychiatrie, Psychotherapie und Neurologie
RECRUITINGRosenheim, 83022, Germany
-
Klinik und Poliklinik für Psychiatrie Regensburg
RECRUITINGRegensburg, 93053, Germany
-
Kliniken Am Goldenen Steig
RECRUITINGFreyung, 94078, Germany
-
Klinikum Aschaffenburg-Alzenau
RECRUITINGAschaffenburg, 63739, Germany
-
Klinikum Bayreuth
RECRUITINGBayreuth, 95445, Germany
-
Klinikum Coburg, Regiomed Zentrum für Altersmedizin
RECRUITINGCoburg, 96450, Germany
-
Klinikum Neumarkt
RECRUITINGNeumarkt, 92318, Germany
-
Klinikum Nürnberg
RECRUITINGNuremberg, 90419, Germany
-
Marion von Tessin Memory-Zentrum
RECRUITINGMünchen, 80335, Germany
-
RHÖN-KLINIKUM Campus Bad Neustadt
RECRUITINGBad Neustadt an der Saale, 97616, Germany
-
Schön Klinik Bad Aibling
RECRUITINGBad Aibling, 83043, Germany
-
Schön Klinik München Schwabing
RECRUITINGMünchen, 80804, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glutathione, brain metabolism and inflammation in Alzheimer's disease
- Can an experimental infusion reach the brain to fight Alzheimer's?
- A new roadmap to predict Alzheimer's before memory fails
- Can a 500-Person study unlock Alzheimer's early signs?
- AI hunts for early clues to Parkinson's and Alzheimer's progression
- Can a daily supplement slow early Alzheimer's memory decline?